Ursula Amstutz
Tacrolimus monitoring in hair samples of kidney transplant recipients.
Born A, Bocchi F, Kuhn C, Amstutz U, Baumgartner M, Sidler D. Tacrolimus monitoring in hair samples of kidney transplant recipients. Front Med (Lausanne) 2023; 10:1307505.
04.12.2023Tacrolimus monitoring in hair samples of kidney transplant recipients.
04.12.2023Front Med (Lausanne) 2023; 10:1307505
Born Alexander, Bocchi Federica, Kuhn Christian, Amstutz Ursula, Baumgartner Matthias R, Sidler Daniel
DNA Methylation Landscapes of Prostate Cancer Brain Metastasis Are Shaped by Early Driver Genetic Alterations.
Gallon J, Rodriguez-Calero A, Benjak A, Akhoundova D, Maletti S, Amstutz U, Hewer E, Genitsch V, Fleischmann A, Rushing E, Grobholz R, Fischer I, Jochum W, Cathomas G, Osunkoya A, Bubendorf L, Moch H, Thalmann G, Feng F, Gillessen S, Chiang C, Rubin M, Piscuoglio S. DNA Methylation Landscapes of Prostate Cancer Brain Metastasis Are Shaped by Early Driver Genetic Alterations. Cancer Res 2023; 83:1203-1213.
14.04.2023DNA Methylation Landscapes of Prostate Cancer Brain Metastasis Are Shaped by Early Driver Genetic Alterations.
14.04.2023Cancer Res 2023; 83:1203-1213
Gallon John, Rodriguez-Calero Antonio, Benjak Andrej, Akhoundova Dilara, Maletti Sina, Amstutz Ursula, Hewer Ekkehard, Genitsch Vera, Fleischmann Achim, Rushing Elisabeth Jane, Grobholz Rainer, Fischer Ingeborg, Jochum Wolfram, Cathomas Gieri, Osunkoya Adeboye O, Bubendorf Lukas, Moch Holger, Thalmann George N, Feng Felix Y, Gillessen Silke, Chiang Charleston W K, Rubin Monika Afzali, Piscuoglio Salvatore
Comparison of methods for donor-derived cell-free DNA quantification in plasma and urine from solid organ transplant recipients.
Kueng N, Arcioni S, Sandberg F, Kuhn C, Banz V, Largiadèr C, Sidler D, Amstutz U. Comparison of methods for donor-derived cell-free DNA quantification in plasma and urine from solid organ transplant recipients. Front Genet 2023; 14:1089830.
27.01.2023Comparison of methods for donor-derived cell-free DNA quantification in plasma and urine from solid organ transplant recipients.
27.01.2023Front Genet 2023; 14:1089830
Kueng Nicholas, Arcioni Séverine, Sandberg Fanny, Kuhn Christian, Banz Vanessa, Largiadèr Carlo R, Sidler Daniel, Amstutz Ursula
Clinical Implementation of Pharmacogenetic Testing to Prevent Early-Onset Fluoropyrimidine-Related Toxicity in Cancer Patients in Switzerland.
Begré U, Jörger M, Aebi S, Amstutz U, Largiadèr C. Clinical Implementation of Pharmacogenetic Testing to Prevent Early-Onset Fluoropyrimidine-Related Toxicity in Cancer Patients in Switzerland. Front Pharmacol 2022; 13:885259.
18.05.2022Clinical Implementation of Pharmacogenetic Testing to Prevent Early-Onset Fluoropyrimidine-Related Toxicity in Cancer Patients in Switzerland.
18.05.2022Front Pharmacol 2022; 13:885259
Begré Ursina B M, Jörger Markus, Aebi Stefan, Amstutz Ursula, Largiadèr Carlo R
Alterations in homologous recombination repair genes in prostate cancer brain metastases.
Rodriguez-Calero A, Gallon J, Akhoundova D, Maletti S, Ferguson A, Cyrta J, Amstutz U, Garofoli A, Paradiso V, Tomlins S, Hewer E, Genitsch V, Fleischmann A, Vassella E, Rushing E, Grobholz R, Fischer I, Jochum W, Cathomas G, Osunkoya A, Bubendorf L, Moch H, Thalmann G, Ng C, Gillessen S, Piscuoglio S, Rubin M. Alterations in homologous recombination repair genes in prostate cancer brain metastases. Nat Commun 2022; 13:2400.
03.05.2022Alterations in homologous recombination repair genes in prostate cancer brain metastases.
03.05.2022Nat Commun 2022; 13:2400
Rodriguez-Calero Antonio, Gallon John, Akhoundova Dilara, Maletti Sina, Ferguson Alison, Cyrta Joanna, Amstutz Ursula, Garofoli Andrea, Paradiso Viola, Tomlins Scott A, Hewer Ekkehard, Genitsch Vera, Fleischmann Achim, Vassella Erik, Rushing Elisabeth J, Grobholz Rainer, Fischer Ingeborg, Jochum Wolfram, Cathomas Gieri, Osunkoya Adeboye O, Bubendorf Lukas, Moch Holger, Thalmann George, Ng Charlotte K Y, Gillessen Silke, Piscuoglio Salvatore, Rubin Mark A
Fluoropyrimidine chemotherapy: recommendations for DPYD genotyping and therapeutic drug monitoring of the Swiss Group of Pharmacogenomics and Personalised Therapy
Hamzic S, Aebi S, Jörger M, Montemurro M, Ansari M, Amstutz U, Largiadèr C. Fluoropyrimidine chemotherapy: recommendations for DPYD genotyping and therapeutic drug monitoring of the Swiss Group of Pharmacogenomics and Personalised Therapy. Swiss Med Wkly 2020; 150:w20375.
24.11.2020Fluoropyrimidine chemotherapy: recommendations for DPYD genotyping and therapeutic drug monitoring of the Swiss Group of Pharmacogenomics and Personalised Therapy
24.11.2020Swiss Med Wkly 2020; 150:w20375
Hamzic Seid, Aebi Stefan, Jörger Markus, Montemurro Michael, Ansari Marc, Amstutz Ursula, Largiadèr Carlo
A Novel Nomenclature for Repeat Motifs in the Thymidylate Synthase Enhancer Region and Its Relevance for Pharmacogenetic Studies
Schaerer D, Froehlich T, Hamzic S, Offer S, Diasio R, Jörger M, Amstutz U, Largiadèr C. A Novel Nomenclature for Repeat Motifs in the Thymidylate Synthase Enhancer Region and Its Relevance for Pharmacogenetic Studies. J Pers Med 2020; 10
19.10.2020A Novel Nomenclature for Repeat Motifs in the Thymidylate Synthase Enhancer Region and Its Relevance for Pharmacogenetic Studies
19.10.2020J Pers Med 2020; 10
Schaerer Dominic, Froehlich Tanja K, Hamzic Seid, Offer Steven M, Diasio Robert B, Jörger Markus, Amstutz Ursula, Largiadèr Carlo R
Evaluating the role of ENOSF1 and TYMS variants as predictors in fluoropyrimidine-related toxicities: An IPD meta-analysis
Hamzic S, Amstutz U, López-Fernández L, García-González X, Schellens J, Meulendijks D, Thomlinson I, Palles C, Aebi S, Jörger M, Froehlich T, Kummer D, Largiadèr C. Evaluating the role of ENOSF1 and TYMS variants as predictors in fluoropyrimidine-related toxicities: An IPD meta-analysis. Pharmacol Res 2019; 152:104594.
12.12.2019Evaluating the role of ENOSF1 and TYMS variants as predictors in fluoropyrimidine-related toxicities: An IPD meta-analysis
12.12.2019Pharmacol Res 2019; 152:104594
Hamzic Seid, Amstutz Ursula, López-Fernández Luis A, García-González Xandra, Schellens Jan H M, Meulendijks Didier, Thomlinson Ian, Palles Claire, Aebi Stefan, Jörger Markus, Froehlich Tanja K, Kummer Dominic, Largiadèr Carlo R
Dihydropyrimidinase and β-ureidopropionase gene variation and severe fluoropyrimidine-related toxicity.
Kummer D, Froehlich T, Joerger M, Aebi S, Sistonen J, Amstutz U, Largiadèr C. Dihydropyrimidinase and β-ureidopropionase gene variation and severe fluoropyrimidine-related toxicity. Pharmacogenomics 2015; 16:1367-77.
05.08.2015Dihydropyrimidinase and β-ureidopropionase gene variation and severe fluoropyrimidine-related toxicity.
05.08.2015Pharmacogenomics 2015; 16:1367-77
Kummer Dominic, Froehlich Tanja K, Joerger Markus, Aebi Stefan, Sistonen Johanna, Amstutz Ursula, Largiadèr Carlo R
Polymorphisms in MIR27A Associated with Early-Onset Toxicity in Fluoropyrimidine-Based Chemotherapy.
Amstutz U, Offer S, Sistonen J, Joerger M, Diasio R, Largiadèr C. Polymorphisms in MIR27A Associated with Early-Onset Toxicity in Fluoropyrimidine-Based Chemotherapy. Clin Cancer Res 2015; 21:2038-44.
05.02.2015Polymorphisms in MIR27A Associated with Early-Onset Toxicity in Fluoropyrimidine-Based Chemotherapy.
05.02.2015Clin Cancer Res 2015; 21:2038-44
Amstutz Ursula, Offer Steven M, Sistonen Johanna, Joerger Markus, Diasio Robert B, Largiadèr Carlo R
Clinical importance of risk variants in the dihydropyrimidine dehydrogenase gene for the prediction of early-onset fluoropyrimidine toxicity
Froehlich T, Amstutz U, Aebi S, Jörger M, Largiadèr C. Clinical importance of risk variants in the dihydropyrimidine dehydrogenase gene for the prediction of early-onset fluoropyrimidine toxicity. Int J Cancer 2014; 136:730-9.
27.06.2014Clinical importance of risk variants in the dihydropyrimidine dehydrogenase gene for the prediction of early-onset fluoropyrimidine toxicity
27.06.2014Int J Cancer 2014; 136:730-9
Froehlich Tanja K, Amstutz Ursula, Aebi Stefan, Jörger Markus, Largiadèr Carlo R